Defibrillator News and Research

Latest Defibrillator News and Research

Interim results from Spectranetics laser atherectomy catheter study on ISR

Spectranetics Corporation today announced six month interim results from the PATENT (Photo-Ablation using the TURBO-Booster and Excimer Laser for In-Stent Restenosis Treatment) study evaluating the safety and efficacy of the Spectranetics peripheral laser atherectomy catheters for the treatment of in-stent restenosis (ISR) in the femoropopliteal artery in the leg.

3 Feb 2012

Two NIH clinical trials to evaluate treatments for out-of-hospital cardiac arrest

The National Institutes of Health has launched two multi-site clinical trials to evaluate treatments for out-of-hospital cardiac arrest. One will compare continuous chest compressions (CCC) combined with pause- free rescue breathing to standard cardiopulmonary resuscitation (CPR), which includes a combination of chest compressions and pauses for rescue breathing.

27 Jan 2012

St. Jude Medical fourth quarter net sales increase 4% to $1.407B

St. Jude Medical, Inc. today reported sales and net earnings for the fourth quarter and year ended December 31, 2011.

25 Jan 2012

GnuBIO to complete development of SCD genetic panel

GnuBIO, Inc., a pioneer in scalable desktop DNA sequencing and the Montreal Heart Institute (MHI) have announced today that they will complete the development of a genetic panel in order to screen patients to determine the risk for sudden cardiac death, SCD.

12 Jan 2012

Cameron Health's PMA application for S-ICD System submitted to FDA

Cameron Health, Inc. announced today that it has submitted the Premarket Approval application to the Food and Drug Administration for the S-ICD System, the world's only completely subcutaneous implantable defibrillator.

9 Jan 2012

Cardiovascular leaders to review data for Riata and Riata ST ICD leads

Cardiovascular leaders will gather in Minneapolis for a one-day summit on Jan. 20, to review data for Riata and Riata ST implantable cardioverter-defibrillator (ICD) leads, which recently underwent a Class I FDA recall. Physicians from the Minneapolis Heart Institute Foundation and Mayo Clinic have organized the summit to develop a consensus regarding the management of patients who have these leads.

4 Jan 2012

Cutting cardiac sympathetic nerve may help control heart rhythms

What do sweaty palms and abnormal heart rhythms have in common? Both can be initiated by the nervous system during adrenaline-driven "flight or fight" stress reaction when the body senses danger.

20 Dec 2011

Clinical trials highlight beneficial effect of CRT in heart failure

However, large-scale clinical trials have highlighted the beneficial effect of cardiac resynchronisation therapy (CRT) in the improvement of symptoms and reduction of mortality, and CRT is now recommended in the major European and American guidelines for the treatment and prevention of heart failure.

19 Dec 2011

Global external defibrillators market to grow at 6% CAGR to exceed $2.2 billion by 2017

Global Information, Inc. (GII) presents "External Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" by GlobalData.

2 Dec 2011

First systematic and in-depth analysis of cardiac arrest in hospital

Only a few decades ago, sudden cardiac arrest was a death sentence. Today, a victim of sudden cardiac arrest is saved roughly once every six hours in Sweden, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden, reviewing all cases of sudden cardiac arrest over a 30-year period.

24 Nov 2011

MedSolutions introduces ICD Surgery Management Program

MedSolutions, a leading provider of quality-driven medical cost management services, today announced the launch of its Implantable Cardioverter Defibrillator (ICD) Surgery Management Program, which uses evidence-based guidelines to ensure the clinical appropriateness of ICD and CRT-D implantation.

19 Nov 2011

Data shows cost-effectiveness of ZOLL LifeVest Wearable Defibrillator

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that data showing the cost-effectiveness of the LifeVest Wearable Defibrillator was presented in two scientific presentations and posters at the American Heart Association's Scientific Sessions 2011 in Orlando over the weekend.

14 Nov 2011

Wearable defibrillator effective in preventing sudden death in people with arrhythmias

A wearable defibrillator can prevent sudden death in people with dangerous heart arrhythmias, according to research presented at the American Heart Association's Scientific Sessions 2011.

14 Nov 2011

Latest advances in cardiovascular medicine, science and education to be presented at AHA 2011

Perelman School of Medicine at the University of Pennsylvania faculty will be involved in presenting research findings on the latest advances in cardiovascular medicine, science, and education at the 2011 American Heart Association Scientific Sessions, in Orlando, FL, November 12 - 16, 2011.

14 Nov 2011

ZOLL to display resuscitation technology, temperature management solutions at AHA 2011

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that 27 scientific presentations related to ZOLL products and technology are scheduled to be presented during the American Heart Association (AHA) 2011 Resuscitation Science Symposium (ReSS) and Scientific Sessions.

10 Nov 2011

Treatments can help most HCM patients

Most of the 600,000 Americans with hypertrophic cardiomyopathy (HCM) -- a genetic heart muscle disease -- can live normal life spans, according to the first science-based guideline for diagnosing and treating this disorder.

9 Nov 2011

More than 50,000 patients at high risk of SCA have been prescribed ZOLL's LifeVest

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that more than 50,000 patients at high risk of sudden cardiac arrest (SCA) have been prescribed the LifeVest Wearable Defibrillator.

29 Oct 2011

Sorin Group third quarter revenues decrease 2.1% to €171.4 million

Sorin Group: Revenues of €171.4 million, a 2.1% decline (-4.9% as reported) over the same period last year.

29 Oct 2011

Largest prospective study of MRI in patients with implanted devices

Magnetic Resonance Imaging (MRI), an important diagnostic test, has traditionally been off limits to more than 2 million people in the United States who have an implanted pacemaker to regulate heart rhythms or an implanted defibrillator to prevent sudden cardiac death.

4 Oct 2011

First patient in Turkey with Total Artificial Heart attends TUYOD meeting

In May 2011, Omer Bayrak made headlines when he became the first patient in Turkey to be discharged from the hospital using the Freedom® portable driver to power his SynCardia temporary Total Artificial Heart. Since returning home to wait for a matching donor heart, Mr. Bayrak has been enjoying his new-found celebrity as "the only man in Turkey who lives without a heart."

30 Sep 2011